{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T20:20:27Z","timestamp":1789158027683,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,7,22]],"date-time":"2023-07-22T00:00:00Z","timestamp":1689984000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,22]],"date-time":"2023-07-22T00:00:00Z","timestamp":1689984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82070763"],"award-info":[{"award-number":["82070763"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Nature Science Foundation of Liaoning Province","award":["2020JH2\/10300045"],"award-info":[{"award-number":["2020JH2\/10300045"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-023-03682-2","type":"journal-article","created":{"date-parts":[[2023,7,22]],"date-time":"2023-07-22T04:01:50Z","timestamp":1689998510000},"page":"699-706","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Colquhounia root tablet in the treatment of idiopathic membranous nephropathy with subnephrotic proteinuria"],"prefix":"10.1007","volume":"56","author":[{"given":"Chunyan","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianhua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zilong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,22]]},"reference":[{"key":"3682_CR1","first-page":"2020071082","volume":"32","author":"S Sethi","year":"2020","unstructured":"Sethi S (2020) New \u2018antigens\u2019 in membranous nephropathy. J Am Soc Nephrol 32:2020071082","journal-title":"J Am Soc Nephrol"},{"key":"3682_CR2","doi-asserted-by":"publisher","first-page":"983","DOI":"10.2215\/CJN.11761116","volume":"12","author":"WG Couser","year":"2017","unstructured":"Couser WG (2017) Primary membranous nephropathy. Clin J Am Soc Nephro 12:983\u2013997","journal-title":"Clin J Am Soc Nephro"},{"key":"3682_CR3","first-page":"61","volume":"2","author":"AM Davison","year":"1984","unstructured":"Davison AM, Cameron JS, Kerr DN, Ogg CS et al (1984) The natural history of renal function in untreated idiopathic membranous glomerulonephritis in adults. Clin Nephrol 2:61\u201367","journal-title":"Clin Nephrol"},{"key":"3682_CR4","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.2215\/CJN.01330209","volume":"9","author":"MA Hladunewich","year":"2009","unstructured":"Hladunewich MA, Troyanov S, Calafati J, Cattran DC (2009) The natural history of the non-nephrotic membranous nephropathy patient. Clin J Am Soc Nephro 9:1417\u20131422","journal-title":"Clin J Am Soc Nephro"},{"key":"3682_CR5","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1159\/000481635","volume":"47","author":"AS Bomback","year":"2018","unstructured":"Bomback AS, Fervenza FC (2018) Membranous nephropathy: approaches to treatment. Am J Nephrol 47:30\u201342","journal-title":"Am J Nephrol"},{"key":"3682_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.fitote.2019.104190","volume":"137","author":"H Lv","year":"2019","unstructured":"Lv H, Jiang L, Zhu M, Li Y et al (2019) The genus Tripterygium: a phytochemistry and pharmacological review. Fitoterapia 137:104190","journal-title":"Fitoterapia"},{"key":"3682_CR7","doi-asserted-by":"publisher","first-page":"161","DOI":"10.2478\/jtim-2021-0021","volume":"9","author":"X Wang","year":"2021","unstructured":"Wang X, Lang R, Liang Y, Zeng Q et al (2021) Traditional Chinese medicine in treating IgA nephropathy: from basic science to clinical research. J Transl Med 9:161\u2013167","journal-title":"J Transl Med"},{"key":"3682_CR8","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13020-021-00563-7","volume":"17","author":"Z Ma","year":"2022","unstructured":"Ma Z (2022) Repurposing a clinically approved prescription Colquhounia root tablet to treat diabetic kidney disease via suppressing PI3K\/AKT\/NF-kB activation. Chin Med-UK 17:2\u201313","journal-title":"Chin Med-UK"},{"key":"3682_CR9","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1038\/ki.2013.276","volume":"84","author":"Y Zhong","year":"2013","unstructured":"Zhong Y, Deng Y, Chen Y, Chuang PY et al (2013) Therapeutic use of traditional Chinese herbal medications for chronic kidney diseases. Kidney Int 84:1108\u20131118","journal-title":"Kidney Int"},{"issue":"5","key":"3682_CR10","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1053\/j.ajkd.2013.12.006","volume":"63","author":"AS Levey","year":"2014","unstructured":"Levey AS, Inker LA, Coresh J (2014) GFR estimation: from physiology to public health. Am J Kidney Dis 63(5):820\u2013834","journal-title":"Am J Kidney Dis"},{"key":"3682_CR11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1159\/000484717","volume":"4","author":"JH Hou","year":"2018","unstructured":"Hou JH, Zhu HX, Zhou ML, Le WB et al (2018) Changes in the spectrum of kidney diseases: an analysis of 40,759 biopsy-proven cases from 2003 to 2014 in China. Kidney Diseases 4:10\u201319","journal-title":"Kidney Diseases"},{"key":"3682_CR12","doi-asserted-by":"publisher","first-page":"994","DOI":"10.3389\/fphar.2020.00994","volume":"11","author":"Z Feng","year":"2020","unstructured":"Feng Z, Liu W, Jiang HX (2020) How does herbal medicine treat idiopathic membranous nephropathy? Front Pharmacol 11:994","journal-title":"Front Pharmacol"},{"issue":"1","key":"3682_CR13","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41572-021-00303-z","volume":"7","author":"P Ronco","year":"2021","unstructured":"Ronco P, Beck L, Debiec H, Fervenza FC et al (2021) Membranous nephropathy. Nat Rev Dis Primers 7(1):69","journal-title":"Nat Rev Dis Primers"},{"key":"3682_CR14","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.kint.2016.09.048","volume":"91","author":"DC Cattran","year":"2017","unstructured":"Cattran DC, Brenchley PE (2017) Membranous nephropathy: integrating basic science into improved clinical management. Kidney Int 91:566\u2013574","journal-title":"Kidney Int"},{"key":"3682_CR15","first-page":"235","volume":"27","author":"EP McQuarrie","year":"2012","unstructured":"McQuarrie EP, Stirling CM, Geddes CC (2012) Idiopathic membranous nephropathy and nephrotic syndrome: outcome in the era of evidence-based therapy. NDT 27:235\u2013242","journal-title":"NDT"},{"key":"3682_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.907108","volume":"13","author":"YN Wang","year":"2022","unstructured":"Wang YN, Feng HY, Nie X, Zhang YM et al (2022) Recent advances in clinical diagnosis and pharmacotherapy options of membranous nephropathy. Front Pharmaco 13:907108","journal-title":"Front Pharmaco"},{"key":"3682_CR17","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.kint.2021.05.015","volume":"100","author":"BH Rovin","year":"2021","unstructured":"Rovin BH, Adler SG, Barratt J (2021) KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int 100:271\u2013276","journal-title":"Kidney Int"},{"key":"3682_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0110681","volume":"9","author":"E Hoxha","year":"2014","unstructured":"Hoxha E, Harendza S, Pinnschmidt H, Panzer U et al (2014) PLA2R antibody levels and clinical outcome in patients with membranous nephropathy and non-nephrotic range proteinuria under treatment with inhibitors of the renin-angiotensin system. PLoS ONE 9:110681","journal-title":"PLoS ONE"},{"key":"3682_CR19","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1089\/acm.2008.0142","volume":"14","author":"S Xue","year":"2008","unstructured":"Xue S, Wu T (2008) Chinese Herbal Medicine Tripterygium hypoglaucum hutch tablet for facial corticosteroid addiction dermatitis. J Altern Complem Med 14:619\u2013624","journal-title":"J Altern Complem Med"},{"key":"3682_CR20","doi-asserted-by":"publisher","first-page":"715359","DOI":"10.3389\/fphar.2021.715359","volume":"12","author":"J Zhao","year":"2021","unstructured":"Zhao J, Zhang F, Xiao X, Wu Z et al (2021) Tripterygium hypoglaucum (L\u00e9vl.) hutch and its main bioactive components: recent advances in pharmacological activity, pharmacokinetics and potential toxicity. Front Pharmacol 12:715359","journal-title":"Front Pharmacol"},{"key":"3682_CR21","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1038\/ki.2010.41","volume":"77","author":"ZH Chen","year":"2010","unstructured":"Chen ZH, Qin WS, Zeng CH, Zheng CX et al (2010) Triptolide reduces proteinuria in experimental membranous nephropathy and protects against C5b-9-induced podocyte injury in vitro. Kidney Int 77:974\u2013988","journal-title":"Kidney Int"},{"key":"3682_CR22","doi-asserted-by":"crossref","unstructured":"Wang S, Li R, He S, He L, et al. Tripterygium wilfordii glycosides upregulate the new anti-inflammatory cytokine IL-37 through ERK1\/2 and p38 MAPK signal pathways. Evid Based Compl Alt. 2017; 9148523.","DOI":"10.1155\/2017\/9148523"},{"key":"3682_CR23","first-page":"2749","volume":"27","author":"L Fang","year":"2018","unstructured":"Fang L, Lu B, Zhang L, Shen LW et al (2018) Effect of colquhounia root on the expression of Angptl2 and NF-\u03baB in kidney of rats with diabetic nephropathy. World J Integr Tradit West Med 27:2749\u20132753","journal-title":"World J Integr Tradit West Med"},{"key":"3682_CR24","first-page":"23","volume":"10","author":"Y Zhou","year":"2016","unstructured":"Zhou Y, Hong Y, Huang H (2016) Triptolide attenuates inflammatory response in membranous glomerulo nephritis rat via downregulation of NF-\u03baB signaling pathway. Kidney Blood Press Res 10:23\u201335","journal-title":"Kidney Blood Press Res"},{"key":"3682_CR25","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF02828210","volume":"25","author":"Z Hongbing","year":"2005","unstructured":"Hongbing Z, Wei C (2005) Effect of colquhoumia root on the expression of transforming growth factor-\u03b2 in mesangial proliferation glomerulonephritis model. J Huazhong U Sci-Med 25:412\u2013415","journal-title":"J Huazhong U Sci-Med"},{"key":"3682_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.969930","volume":"13","author":"H Miao","year":"2022","unstructured":"Miao H, Zhang Y, Yu X (2022) Membranous nephropathy: systems biology-based novel mechanism and traditional Chinese medicine therapy. Front Pharmacol 13:969930","journal-title":"Front Pharmacol"},{"key":"3682_CR27","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1053\/j.ajkd.2013.05.005","volume":"62","author":"Y Chen","year":"2013","unstructured":"Chen Y, Deng Y, Ni Z, Chen N et al (2013) Efficacy and safety of traditional Chinese medicine (Shenqi particle) for patients with idiopathic membranous nephropathy: a multicenter randomized controlled clinical tria. Am J Kidney Dis 62:1068\u20131076","journal-title":"Am J Kidney Dis"},{"issue":"16","key":"3682_CR28","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s12882-015-0199-x","volume":"4","author":"S Liu","year":"2015","unstructured":"Liu S, Li X, Li H, Liang Q et al (2015) Comparison of Tripterygium wilfordii multiglycosides and tacrolimus in the treatment of idiopathic membranous nephropathy: a prospective cohort study. BMC Nephrol 4(16):200","journal-title":"BMC Nephrol"},{"issue":"1","key":"3682_CR29","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s12882-018-0967-5","volume":"19","author":"SL Shang","year":"2018","unstructured":"Shang SL, Cai GY, Duan SW (2018) Retrospective analysis of tacrolimus combined with Tripterygium wilfordii polyglycoside for treating idiopathic membranous nephropathy. BMC Nephrol 19(1):182","journal-title":"BMC Nephrol"},{"issue":"11","key":"3682_CR30","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1038\/ki.2010.41","volume":"77","author":"ZH Chen","year":"2010","unstructured":"Chen ZH (2010) Triptolide reduces proteinuria in experimental membranous nephropathy and protects against C5b-9-induced podocyte injury in vitro. Kidney Int 77(11):974\u2013988","journal-title":"Kidney Int"},{"issue":"2","key":"3682_CR31","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nrneph.2015.215","volume":"12","author":"D Zhou","year":"2016","unstructured":"Zhou D, Liu Y (2016) Renal fibrosis in 2015: understanding the mechanisms of kidney fibrosis. Nat Rev Nephrol 12(2):68\u201370","journal-title":"Nat Rev Nephrol"},{"key":"3682_CR32","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1053\/j.ajkd.2013.02.374","volume":"62","author":"B Zhu","year":"2013","unstructured":"Zhu B, Wang Y, Jardine M, Min J et al (2013) Tripterygium preparations for the treatment of CKD: a systematic review and meta-analysis. Am J Kidney Dis 62:515\u2013530","journal-title":"Am J Kidney Dis"},{"key":"3682_CR33","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1053\/j.ajkd.2020.10.009","volume":"77","author":"L Alsharhan","year":"2021","unstructured":"Alsharhan L, Beck LH (2021) Membranous nephropathy: core curriculum 2021. Am J Kidney Dis 77:440\u2013453","journal-title":"Am J Kidney Dis"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-023-03682-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-023-03682-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-023-03682-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T17:10:09Z","timestamp":1706116209000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-023-03682-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,22]]},"references-count":33,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["3682"],"URL":"https:\/\/doi.org\/10.1007\/s11255-023-03682-2","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,22]]},"assertion":[{"value":"1 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors affirm that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures were in accordance with the standards of the Clinical Research Ethics Committee of the First Affiliated Hospital of China Medical University (2022-318) and the 1964 Declaration of Helsinki and its subsequent amendments. Everyone who took part in this study provided their informed permission.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to the participate"}}]}}